Compass Therapeutics Inc. (CMPX NASDAQ) stock market data APIs
$0.7613
-0.06(-7.9%)
as of November 6, 2026
Try our APIs with
free plan!
Compass Therapeutics Inc. Financial Data Overview
Price chart is built with
Anychart
Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, develops antibody-based therapeutics for the treatment of various human diseases in the United States. The company's lead product candidate, tovecimig, is a bispecific antibody that targets delta-like ligand 4 (DLL4) and vascular endothelial growth factor A (VEGF-A), which are critical to angiogenesis and tumor vascularization. It also develops CTX-471, an IgG4 monoclonal antibody that is an agonist of CD137, a key co-stimulatory receptor on immune cells; CTX-8371, a bispecific inhibitor that targets programmed cell death protein-1 (PD-1) and ligand PD-L1 checkpoint inhibitor antibodies; and CTX-10726, a bispecific antibody that targets PD-1 and VEFG-A. The company was founded in 2014 and is headquartered in Boston, Massachusetts.
Prev. Close
0.7613
Open
0.7061
High
0.7613
Low
0.6647
52 wk Range
0.6714-6.88
Market Cap
137 M
Shares Outstanding
180 M
EPS
-0.08
Beta
1.059
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Compass Therapeutics Inc. (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Compass Therapeutics Inc. data using free add-ons & libraries
Get Compass Therapeutics Inc. Fundamental Data
Compass Therapeutics Inc. Fundamental data includes:
- Net Revenue:
- EBITDA: -81 013 000
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Compass Therapeutics Inc. Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-11-04
- EPS/Forecast: -0.12
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Compass Therapeutics Inc. News
New
Compass Therapeutics Reports 2026 Third Quarter Financial Results and Provides Corporate Update
Compass Therapeutics Compass is advancing preparations for a BLA submission for tovecimig in patients with BTC and plans to further engage with the FDA. Data from the COMPANION-002 study of tovecimig...
Compass Therapeutics Presents Novel Mechanism of Action Data for CTX-10726 (PD-1 x VEGF-A Bispecific Antibody) at the SITC 2026 Annual Meeting
Compass Therapeutics CTX-10726, a PD-1 x VEGF-A bispecific antibody discovered and engineered at Compass, exhibits a unique mechanism of action that has not been previously reported in this class of ...
Compass Therapeutics to Participate in Upcoming November Investor Events
Compass Therapeutics BOSTON, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-...
Emergent BioSolutions stock falls as CFO plans retirement
Investing.com -- Emergent Biosolutions Inc (NYSE:EBS) shares dropped 1292% Friday after the company announced that Chief Financial Officer Richard Lindahl will retire at the end of 2026. Still guessi...
Get Compass Therapeutics Inc. fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.